Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$24,986.00

Development of a Parallel Radiofrequency Transmission Subsystem for MRI at 3 Tesla

FY 2017-18

Summary
Per Vices Corporation is a Toronto-based company that makes high quality software defined radio (SDR)devices. Historically, radios consisted of multiple electronic components with different signal processingfunctions; SDR now enables much of this hardware to be streamlined and performed using a personalcomputer, in communication with a real-time computer embedded in one electronic device. Extensive softwareis now widely available to operate SDRs for many commercial applications, for example intelecommunications and in security.Per Vices is interested in expanding the market for its devices into the healthcare sector. In particular,radiofrequency transmission is a critical element of clinical magnetic resonance imaging (MRI) systems. PerVices hopes to combine their expertise in SDR with that of Dr. Simon Graham, an MRI physicist and engineer,to enable use of Per Vices technology in this context. Per Vices and Dr. Graham will undertake initial researchand development to verify and validate that the company's ""Crimson SDR"" device facilitates an emergingtechnique called parallel radiofrequency transmission (PTX) on a clinical-grade MRI system. PTX hassubstantial potential to improve clinical MRI capabilities, but the enabling infrastructure is not widelyavailable. If successful, the Crimson SDR could become the central component of a new PTX hardwareproduct that could be sold to the research MRI community, and ultimately to multi-national MRI systemvendors.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
515219-2017
Name nom
Graham, Simon
Department département
Medical Biophysics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
24986
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Development of a Parallel Radiofrequency Transmission Subsystem for MRI at 3 Tesla
Keyword
NSERC
Application summary
Per Vices Corporation is a Toronto-based company that makes high quality software defined radio (SDR)devices. Historically, radios consisted of multiple electronic components with different signal processingfunctions; SDR now enables much of this hardware to be streamlined and performed using a personalcomputer, in communication with a real-time computer embedded in one electronic device. Extensive softwareis now widely available to operate SDRs for many commercial applications, for example intelecommunications and in security.Per Vices is interested in expanding the market for its devices into the healthcare sector. In particular,radiofrequency transmission is a critical element of clinical magnetic resonance imaging (MRI) systems. PerVices hopes to combine their expertise in SDR with that of Dr. Simon Graham, an MRI physicist and engineer,to enable use of Per Vices technology in this context. Per Vices and Dr. Graham will undertake initial researchand development to verify and validate that the company's ""Crimson SDR"" device facilitates an emergingtechnique called parallel radiofrequency transmission (PTX) on a clinical-grade MRI system. PTX hassubstantial potential to improve clinical MRI capabilities, but the enabling infrastructure is not widelyavailable. If successful, the Crimson SDR could become the central component of a new PTX hardwareproduct that could be sold to the research MRI community, and ultimately to multi-national MRI systemvendors.